4 Cutting-Edge Healthcare Stocks To Buy For 2021

While some say the future is tech, I’d like to add another sector to that viewpoint… healthcare. Healthcare has previously been considered a defensive sector, but with the growth in biotech and medical services companies to meet the demands of the coronavirus pandemic, the future of these industries, and the sector overall, look quite promising. Which is why I’m highlighting four stocks today that could soar in 2021 and beyond.

Beyond COVID, the future of healthcare will gain from an aging global population and a growing middle class in developing countries. These demographics will demand more treatments and medical care over time, leading to a boom for the sector. That’s why I am looking at innovative companies that can fill the gap between current healthcare needs and the future. 

Each of the following healthcare companies has the potential to deliver incredible returns over the long-term: Seattle Genetics, Inc. (SGEN - Get Rating), Amedisys Inc. (AMED - Get Rating), LHC Group (LHCG - Get Rating), and Masimo Corporation (MASI - Get Rating).

Seattle Genetics, Inc. (SGEN - Get Rating)

SGEN is a biotech company that focuses on developing cancer therapeutics. Its lead lymphoma drug, Adcetris, has performed very well since it launched, and it is the primary growth catalyst for the company. The drug’s label has also expanded, which has provided more revenue for the company. The company also has several drugs in its pipeline testing in phase 3 trials for a wide range of cancers.

Once these drugs are approved, it will provide the company more cash to fund new drug development. SGEN also received approval for Padcev to treat patients with metastatic bladder cancer and Tukysa to treat metastatic HER2-positive breast cancer. The company has a deal with Merck (MRK), which plans to buy a 2.9% stake in the company. The two companies are co-developing and selling SGEN’s breast cancer therapy, ladiratuzumab vedotin.

1 2 3
View single page >> |

Disclaimer: Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use, please ...

more
How did you like this article? Let us know so we can better customize your reading experience.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.